SCHEDULE: Gregory Castaldo Discloses 7.5% Stake in Catheter Precision

Gregory Castaldo has disclosed a 7.5% beneficial ownership stake in Catheter Precision, Inc., holding 176,674 shares of common stock.

Summary

• Gregory Castaldo, a U.S. citizen, has filed a Schedule 13G disclosing beneficial ownership of Catheter Precision, Inc. common stock.
• Mr. Castaldo beneficially owns 176,674 shares of Catheter Precision, Inc. common stock.
• This ownership represents 7.5% of the company's outstanding common stock.
• The percentage is based on 2,357,127 shares of Common Stock outstanding as verified with the Issuer on February 11, 2026.
• Mr. Castaldo holds sole voting power and sole dispositive power over all 176,674 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It is a standard regulatory disclosure of beneficial ownership and does not contain information that would significantly alter the fundamental sentiment towards the company, though a new significant shareholder can be seen positively.

Positives

• The disclosure of a significant individual shareholder, Gregory Castaldo, holding 7.5% of the common stock, may signal confidence in Catheter Precision, Inc.

Negatives

• This filing is a factual disclosure of beneficial ownership and does not inherently contain negative financial or operational information about the company.

Risks

• This filing is a disclosure of beneficial ownership and does not detail specific risks related to Catheter Precision, Inc.'s operations or financial health.

Future Outlook

This Schedule 13G filing is a disclosure of current beneficial ownership and does not contain any forward-looking statements or guidance regarding Catheter Precision, Inc.'s future outlook.

Industry Context

StockSavvy.ai notes that a Schedule 13G filing by an individual investor, while not directly tied to broader industry trends, can sometimes reflect an investor's belief in the long-term prospects of a company within its sector, particularly in the medical device or healthcare technology space where Catheter Precision operates.

Stakeholder Impact

• Shareholders: The disclosure provides transparency regarding a significant individual shareholder's stake, which can influence investor perception and potentially liquidity.
• Company Management: Awareness of a significant passive shareholder may be noted, though the filing certifies no intent to influence control.

Key Dates

Keywords

Catheter Precision, Gregory Castaldo, Beneficial Ownership, Schedule 13G, Common Stock, SEC Filing, Ownership Stake